GSK makes $2.2B deal for RAPT and its food allergy candidate
GSK makes $2.2B deal for RAPT and its food allergy candidate
Body unavailable. Use the original source.
GSK makes $2.2B deal for RAPT and its food allergy candidate
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.